Courtesy of Dr. Pablo Baglioni. The visual interpretation of coronary angiographies is still used to decide for or against revascularization of ambiguous coronary lesions. Multiple factors other than stenosis degree, have been associated with the functional significance of lesions. The aim of this study was to analyze the ability of interventionists to visually assess...
Original Title: 6-Month versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation. The IVUS-XPL Randomized Clinical Trial. Reference: Hong et al. JACC Cardiovasc Interv. 2016 May 11. [Epub ahead of print] Courtesy of Dr. Brian Nazareth Donato. This publication stems from the IVUS-XPL published by JAMA in November 2015. This study presents outcomes on the...
Original Title: Tissue Protrusion after Stent Implantation. An ADAPT-DES Intravascular Ultrasound Substudy. Reference: Fuyu Qiu et al. J Am Coll Cardiol Intv. 2016;9(14):1499-1507. After DES implantation we may observe tissue protrusion (plaque or thrombus) relatively often, especially in unstable lesions; however, its clinical impact has not been studied. The aim of this study was...
Original Title: Predictors of Restenosis Following Carotid Angioplasty and Stenting. Reference: Elena Zapata-Arriaza et al. Stroke. 2016 Jun 21. Epub ahead of print. Restenosis after carotid PCI is associated to an increase of stroke and death risk. The purpose of this study was to determine the risk and predicting factors associated to carotid restenosis...
Original Title: Paclitaxel-eluting balloon versus standard balloon angioplasty in in-stent restenosis of the superficial femoral and proximal popliteal artery: 1-year results of the PACUBA trial. Reference: Kinstner CM et al. J Am Coll Cardiol Intv. 2016;9:1386-1392. Patients with symptomatic femoropopliteal in-stent restenosis (ISR) have better patency at one year if treated with drug eluting...
Original Title: Ticagrelor for Prevention of Ischemic Events after Myocardial Infarction in Patients with Peripheral Artery Disease. Reference: Marc P. Bonaca et al. J Am Coll Cardiol. 2016 Jun 14;67(23):2719-28. Peripheral artery disease is associated with high rates of ischemic and bleeding events in patients with prior myocardial infarction. This study evaluates the safety...
Original Title: Long-Term Mortality in Patients With Radiation-Associated Coronary Artery Disease Treated with Percutaneous Coronary Intervention. Reference: Reed GW et al. Circ Cardiovasc Interv. 2016 Jun;9(6). Courtesy of Dr. Brian Nazareth Donato. Radiotherapy is often used to treat malignant tumors; however, it is associated with adverse cardiovascular effects such as constrictive pericarditis, valve deterioration...
FIRST PLACE 114 THE IMPACT OF POST-PROCEDURAL ASYMMETRY, EXPANSION AND ECCENTRICITY OF BIORESORBABLE EVEROLIMUS-ELUTING SCAFFOLD AND METALLIC EVEROLIMUS-ELUTING STENT ON CLINICAL OUTCOMES IN THE ABSORB II TRIAL PANNIPA SUWANNASOM1; YOHEI SOTOMI1; RAFAEL CAVALCANTE E SILVA2; CARLOS MACAYA3; JOHN A ORMINSTON4; JONATHAN HILL5; MACIEJ LESIAK6; BERNARD CHEVALIER7; PATRICK W SERRUYS8; YOSHINOBU ONUMA2 1.ACADEMIC MEDICAL CENTER, HOLLAND;...
Original Title: Bioresorbable Everolimus-Eluting Vascular Scaffold for Patients With Peripheral Artery Disease (ESPRIT I) 2-Year Clinical and Imaging Results CME. Reference: Johannes Lammer et al. J Am Coll Cardiol Intv. 2016;9(11):1178-1187. This is the first study on humans to assess the bioresorbable everolimus eluting vascular scaffold for the treatment of peripheral artery disease involving...
Original Title: Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes Reference: Shiv K. Agarwal, et al. JACC Cardiovascular Intervention 2016;9:1022-31 Courtesy of Dr. Carlos Fava. Fractional flow reserve has shown benefits and it is considered the gold standard to assess intermediate lesions (Class IA), but its...